Stavros Xanthopoulos

790 total citations
34 papers, 633 citations indexed

About

Stavros Xanthopoulos is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Biomaterials. According to data from OpenAlex, Stavros Xanthopoulos has authored 34 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Oncology and 9 papers in Biomaterials. Recurrent topics in Stavros Xanthopoulos's work include Radiopharmaceutical Chemistry and Applications (28 papers), Peptidase Inhibition and Analysis (11 papers) and Nanoparticle-Based Drug Delivery (9 papers). Stavros Xanthopoulos is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (28 papers), Peptidase Inhibition and Analysis (11 papers) and Nanoparticle-Based Drug Delivery (9 papers). Stavros Xanthopoulos collaborates with scholars based in Greece, Italy and France. Stavros Xanthopoulos's co-authors include Penelope Bouziotis, Alexandra D. Varvarigou, George Loudos, Maria Paravatou‐Petsotas, Dimitrios Psimadas, Christos Zikos, Melpomeni Fani, Eleni Gourni, C. Tsoukalas and S.C. Archimandritis and has published in prestigious journals such as Journal of Colloid and Interface Science, Journal of Medicinal Chemistry and International Journal of Pharmaceutics.

In The Last Decade

Stavros Xanthopoulos

34 papers receiving 619 citations

Peers

Countries citing papers authored by Stavros Xanthopoulos

Since Specialization

Citations

This map shows the geographic impact of Stavros Xanthopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stavros Xanthopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stavros Xanthopoulos more than expected).

Fields of papers citing papers by Stavros Xanthopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stavros Xanthopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stavros Xanthopoulos. The network helps show where Stavros Xanthopoulos may publish in the future.

Co-authorship network of co-authors of Stavros Xanthopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Stavros Xanthopoulos. A scholar is included among the top collaborators of Stavros Xanthopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stavros Xanthopoulos. Stavros Xanthopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	How Does the Concentration of Technetium-99m Radiolabeled Gold Nanoparticles Affect Their In Vivo Biodistribution? 2024 ·Applied Sciences ·(unknown), (unknown), Aristeidis Chiotellis, (unknown), Ioannis Pirmettis, Stavros Xanthopoulos, Przemysław Koźmiński, Penelope Bouziotis	1
2	Optimization of the location and capacity of shared multimodal mobility hubs to maximize travel utility in urban areas 2023 ·Transportation Research Part A Policy and Practice ·Stavros Xanthopoulos, (unknown), Shadi Sharif Azadeh, Gonçalo Homem de Almeida Correia, Niels van Oort, Maaike Snelder	13
3	In vivo biodistribution of edelfosine-loaded lipid nanoparticles radiolabeled with Technetium-99 m: Comparison of administration routes in mice 2022 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), (unknown), Theodoros Tsotakos, Stavros Xanthopoulos, George Loudos, Penelope Bouziotis, María J. Blanco‐Prieto	7
4	A Proof-of-Concept Study on the Therapeutic Potential of Au Nanoparticles Radiolabeled with the Alpha-Emitter Actinium-225 2020 ·Pharmaceutics ·(unknown), Dimitris Stellas, C. Tsoukalas, Barbara Mavroidi, Maria Paravatou‐Petsotas, Nick Kalogeropoulos, Stavros Xanthopoulos, Franck Denat, Gautier Laurent, Rana Bazzi, Stéphane Roux, Penelope Bouziotis	56
5	Co-administration of succinylated gelatine with a 99m Tc-bombesin analogue, effects on pharmacokinetics and tumor uptake 2016 ·Nuclear Medicine and Biology ·Christos Liolios, Stavros Xanthopoulos, George Loudos, Alexandra D. Varvarigou, Gregory Sivolapenko	2
6	Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept study 2016 ·Nuclear Medicine and Biology ·Valery Radchenko, Penelope Bouziotis, Theodoros Tsotakos, (unknown), (unknown), George Loudos, Adrian L. Harris, Stavros Xanthopoulos, Dmitry Filosofov, Harald Hauser, Michael Eisenhut, Bernard Ponsard, Frank Roesch	13
7	Initial in vitro and in vivo assessment of Au@DTDTPA-RGD nanoparticles for Gd-MRI and 68Ga-PET dual modality imaging 2015 ·EJNMMI Physics ·(unknown), Gautier Laurent, (unknown), Theodoros Tsotakos, Rana Bazzi, Dimitris Stellas, Constantinos Anagnostopoulos, Lia A. Moulopoulos, Vassilis Koutoulidis, Maria Paravatou‐Petsotas, Stavros Xanthopoulos, Stéphane Roux, Penelope Bouziotis	5
8	Comparative in vitro stability and scintigraphic imaging for trafficking and tumor targeting of a directly and a novel 99mTc(I)(CO)3 labeled liposome 2014 ·International Journal of Pharmaceutics ·Eirini Fragogeorgi, Irina N. Savina, Theodoros Tsotakos, (unknown), Stavros Xanthopoulos, (unknown), Dimitrios Psimadas, Penelope Bouziotis, Γ. Κορδάς, Sergey V. Mikhalovsky, Mohammad S. Alavijeh, George Loudos	10
9	99m Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of ανβ3 -mediated tumor expression and feasibility for hyperthermia treatment 2014 ·Journal of Colloid and Interface Science ·(unknown), Eleni Κ. Efthimiadou, Eirini Fragogeorgi, George Loudos, Alexandra D. Varvarigou, Penelope Bouziotis, Γ. Κορδάς, D Mihailidis, George Nikiforidis, Stavros Xanthopoulos, Dimitrios Psimadas, Maria Paravatou‐Petsotas, (unknown), John D. Hazle, George C. Kagadis	45
10	Radiochemical and radiobiological assessment of a pyridyl-S-cysteine functionalized bombesin derivative labeled with the 99mTc(CO)3+ core 2013 ·Bioorganic & Medicinal Chemistry ·Penelope Bouziotis, Eleni Gourni, G. P. Patsis, Dimitrios Psimadas, Christos Zikos, Melpomeni Fani, Stavros Xanthopoulos, George Loudos, Maria Paravatou‐Petsotas, Evangelia Livaniou, Alexandra D. Varvarigou, Ioannis Pirmettis, Minas Papadopoulos	4
11	Biological evaluation of an ornithine-modified 99mTc-labeled RGD peptide as an angiogenesis imaging agent 2012 ·Nuclear Medicine and Biology ·(unknown), George Loudos, Alexandra D. Varvarigou, Eirini Fragogeorgi, Dimitrios Psimadas, Theodoros Tsotakos, Stavros Xanthopoulos, D Mihailidis, Penelope Bouziotis, George Nikiforidis, George C. Kagadis	23
12	Synthesis and comparative assessment of a labeled RGD peptide bearing two different 99mTc-tricarbonyl chelators for potential use as targeted radiopharmaceutical 2012 ·Bioorganic & Medicinal Chemistry ·Dimitrios Psimadas, Melpomeni Fani, Eleni Gourni, George Loudos, Stavros Xanthopoulos, Christos Zikos, Penelope Bouziotis, Alexandra D. Varvarigou	17
13	Preliminary Evaluation of a <SUP>99m</SUP>Tc Labeled Hybrid Nanoparticle Bearing a Cobalt Ferrite Core: <I>In Vivo</I> Biodistribution 2012 ·Journal of Biomedical Nanotechnology ·Dimitrios Psimadas, Giovanni Baldi, Costanza Ravagli, Penelope Bouziotis, Stavros Xanthopoulos, Mauro Comes Franchini, Panagiotis Georgoulias, George Loudos	36
14	Structural modifications of 99mTc-labelled bombesin-like peptides for optimizing pharmacokinetics in prostate tumor targeting 2012 ·International Journal of Pharmaceutics ·Christos Liolios, Eirini Fragogeorgi, Christos Zikos, George Loudos, Stavros Xanthopoulos, Penelope Bouziotis, Maria Paravatou‐Petsotas, Evangelia Livaniou, Alexandra D. Varvarigou, Gregory Sivolapenko	29
15	Structural Assessment and Biological Evaluation of Two N₃S Bombesin Derivatives 2009 ·Journal of Medicinal Chemistry ·Eleni Gourni, Penelope Bouziotis, Dimitra Benaki, George Loudos, Stavros Xanthopoulos, Maria Paravatou‐Petsotas, (unknown), Maria Pelecanou, (unknown), Alexandra D. Varvarigou	14
16	Spacer Site Modifications for the Improvement of the in Vitro and in Vivo Binding Properties of ^99mTc-N₃S-X-Bombesin[2−14] Derivatives 2009 ·Bioconjugate Chemistry ·Eirini Fragogeorgi, Christos Zikos, Eleni Gourni, Penelope Bouziotis, Maria Paravatou‐Petsotas, George Loudos, (unknown), Stavros Xanthopoulos, (unknown), Evangelia Livaniou, Alexandra D. Varvarigou, S.C. Archimandritis	24
17	Study of the labeling of two novel RGD-peptidic derivatives with the precursor [99mTc(H2O)3(CO)3]+ and evaluation for early angiogenesis detection in cancer 2005 ·Applied Radiation and Isotopes ·Dimitrios Psimadas, Melpomeni Fani, Christos Zikos, Stavros Xanthopoulos, S.C. Archimandritis, Alexandra D. Varvarigou	12
18	Samarium-153 and technetium-99m-labeled monoclonal antibodies in angiogenesis for tumor visualization and inhibition. 2003 ·PubMed ·(unknown), Melpomeni Fani, S.C. Archimandritis, (unknown), (unknown), Roy Bicknell, Adrian L. Harris, Stavros Xanthopoulos, (unknown), Alexandra D. Varvarigou	6
19	Synthesis, Chemical, Radiochemical and Radiobiological Evaluation of a New ^99m Tc-labelled Bombesin-like Peptide 2002 ·Cancer Biotherapy and Radiopharmaceuticals ·Alexandra D. Varvarigou, Francesco Scopinaro, Leondios Leondiadis, Vito D. Corleto, Orazio Schillaci, Giuseppe De Vincentis, Thomae G. Sourlingas, Kalliope E. Sekeri‐Pataryas, Gregory P. Evangelatos, (unknown), Stavros Xanthopoulos, G. Delle Fave, S.C. Archimandritis	27
20	Labeling of monoclonal antibodies with 153Sm for potential use in radioimmunotherapy 2002 ·Applied Radiation and Isotopes ·Melpomeni Fani, Sanja Vranješ‐Đurić, S.C. Archimandritis, S. Potamianos, Stavros Xanthopoulos, (unknown), Alexandra D. Varvarigou	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact